계명대학교 의학도서관 Repository

Secular Trends in Outcomes and Impact of Novel Oral Anticoagulants in Atrial Fibrillation-Related Acute Ischemic Stroke

Metadata Downloads
Author(s)
Minwoo LeeByung-Chul LeeKyung-Ho YuMi-Sun OhBeom Joon KimJun Yup KimJihoon KangKeon-Joo LeeDo Yeon KimJong-Moo ParkKyusik KangTai Hwan ParkKyung Bok LeeKeun-Sik HongHong-Kyun ParkYong-Jin ChoDong-Eog KimSoo Joo LeeJae Guk KimJun LeeJae-Kwan ChaDae-Hyun KimJoon-Tae KimKang-Ho ChoiJay Chol ChoiSung-Il SohnJeong-Ho HongSang-Hwa LeeChulho KimDong-Ick ShinKyu Sun YumJuneyoung LeeJi Sung LeePhilip B GorelickHee-Joon Bae
Keimyung Author(s)
Sohn, Sung IlHong, Jeong Ho
Department
Dept. of Neurology (신경과학)
Journal Title
Stroke
Issued Date
2024
Volume
55
Issue
3
Keyword
anticoagulationatrial fibrillationdeathischemic strokemajor vascular eventstroke recurrence
Abstract
Background:
Novel oral anticoagulants (NOACs) are currently recommended for the secondary prevention of stroke in patients with acute ischemic stroke (AIS) accompanied by atrial fibrillation (AF). However, the impact of NOACs on clinical outcomes in real-world practice remains ambiguous. This study analyzes the trend of clinical events in patients with AF-related AIS and determines how much the introduction of NOACs has mediated this trend.

Methods:
We identified patients with AIS and AF between January 2011 and December 2019 using a multicenter stroke registry. Annual rates of NOAC prescriptions and clinical events within 1 year were evaluated. The primary outcome was a composite of recurrent stroke, myocardial infarction, and all-cause mortality. To assess the mediation effect of NOACs on the relationship between the calendar year and these outcomes, we used natural effect models and conducted exposure-mediator, exposure-outcome, and mediator-outcome analyses using multivariable regression models or accelerated failure time models, adjusting for potential confounders.

Results:
Among the 12 977 patients with AF-related AIS, 12 500 (average age: 74.4 years; 51.3% male) were analyzed after excluding cases of valvular AF. Between 2011 and 2019, there was a significant decrease in the 1-year incidence of the primary composite outcome from 28.3% to 21.7%, while the NOAC prescription rate increased from 0% to 75.6%. A 1-year increase in the calendar year was independently associated with delayed occurrence of the primary outcome (adjusted time ratio, 1.10 [95% CI, 1.07-1.14]) and increased NOAC prescription (adjusted odds ratio, 2.20 [95% CI, 2.14-2.27]). Increased NOAC prescription was associated with delayed occurrence of the primary outcome (adjusted time ratio, 3.82 [95% CI, 3.17 to 4.61]). Upon controlling for NOAC prescription (mediator), the calendar year no longer influenced the primary outcome (adjusted time ratio, 0.97 [95% CI, 0.94-1.00]). This suggests that NOAC prescription mediates the association between the calendar year and the primary outcome.

Conclusions:
Our study highlights a temporal reduction in major clinical events or death in Korean patients with AF-related AIS, mediated by increased NOAC prescription, emphasizing NOAC use in this population.
Keimyung Author(s)(Kor)
손성일
홍정호
Publisher
School of Medicine (의과대학)
College of Nursing (간호대학)
Type
Article
ISSN
1524-4628
Source
https://www.ahajournals.org/doi/10.1161/STROKEAHA.123.044487
DOI
10.1161/STROKEAHA.123.044487
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/45587
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Neurology (신경과학)
Authorize & License
  • Authorize공개
  • EmbargoForever
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.